comparemela.com

Latest Breaking News On - Thyrocare - Page 2 : comparemela.com

1mg Pharmeasy Market Share: 1mg overtakes PharmEasy in market share in top order change, ET Retail

1mg Pharmeasy Market Share: Tata 1mg had a 31% market share in September 2023 against 19% in October 2022 while PharmEasy slipped to 15% from about 33% during the same period, according to a data analysis by third-party internet market research firm Redseer, which ET has seen.

Diagnostics players have become rational in terms of pricing: Thyrocare CEO

Throcare had normalised EBITDA of 30 percent in Q2 of FY24 and in the same period the previous year.

vimarsana © 2020. All Rights Reserved.